WALTHAM, Mass. (AP) -- PerkinElmer will acquire Signature Genomic Laboratories in a bid to strengthen its genetic testing services, the health sciences company said Wednesday.
Terms of the deal, which is expected to close next month, were not disclosed.
PerkinElmer, based in Waltham, Mass., said Signature will help expand its position in the molecular diagnostics market and strengthen its cancer diagnostics.
"Signature brings very strong complementary assets for diagnosing disorders that are often undetected by traditional genetic tests," PerkinElmer CEO Robert Friel said.
Signature is based in Spokane, Wash. and has about 120 employees.
PerkinElmer Inc. said it employs about 8,500 people and has customers in more than 150 countries. Earlier this year, the company acquired the remaining 50 percent of a joint venture with Danaher Corp.
Danaher initially entered the joint-venture as part of its purchase of the analytical technologies business of MDS Inc.
